Stocks · Healthcare · Medical - Healthcare Plans
Cigna Corporation CI
$270.53 +0.96% Close, Oct 2, 2026 · NYSE · Market cap $71.48B
Inexpensive vs sectorLow risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +2.5%).
- The shares trade at 11.2× trailing earnings, lower than 86% of the company's own readings over the past five years.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 47%
- EPS growth (TTM, YoY)Top 33%
- FCF growth (TTM, YoY)Top 13%
- Revenue growth, 3-year CAGRTop 40%
- Revenue growth accelerationBottom 40%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 19%
- Gross marginBottom 10%
- Operating marginTop 37%
- Cash conversion (OCF / net income)Top 49%
- Accruals (lower is better)Bottom 27%
- Net debt / EBITDA (lower is better)Bottom 37%
- Interest coverTop 20%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 4%
- Free-cash-flow yieldTop 5%
- EBITDA / enterprise valueTop 6%
- Sales / enterprise valueTop 2%
- P/E vs own 5-year history (lower is better)Top 28%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 33%
- 6-month returnBottom 44%
- 1-year return vs S&P 500Bottom 38%
- Distance from 52-week highTop 22%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 48%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyBottom 45%
- Upside to consensus price targetBottom 32%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 7%
- Maximum drawdown, 3 yearsTop 7%
- Beta vs S&P 500 (lower is better)Top 6%
- Net debt / EBITDA (lower is better)Bottom 37%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 8.8% | 7.7% | ↓ |
| EPS growth (YoY) | 30.6% | 31.9% | ↑ |
| Gross margin | 10.5% | 11.7% | ↑ |
| Operating margin | 3.5% | 3.5% | ↓ |
| FCF margin | 1.5% | 3.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 7.7% | 8.8% | ↓ | Bottom 47% |
| EPS growth (TTM, YoY) | 31.9% | 30.6% | ↑ | Top 33% |
| Gross margin | 11.7% | 10.5% | ↑ | Bottom 10% |
| Operating margin | 3.5% | 3.5% | ↓ | Top 37% |
| Net margin | 2.3% | 1.9% | ↑ | — |
| Free-cash-flow margin | 3.2% | 1.5% | ↑ | — |
| Return on invested capital | 7.7% | — | Top 19% | |
| Revenue growth, 3-year CAGR | 15.1% | — | Top 40% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.60×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -2.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -8.9 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 2.17×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 7.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 2.27%
- Net buyback yield (TTM)
- 1.48%
- Shareholder yield
- 3.76%
- Share count change, 1 year
- -1.6%
- Share count change, 3-year CAGR
- -3.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +2.5%
- Average 2-day reaction, last 8
- -4.1%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $342.08
- Target vs current price
- +26.4%
- Analysts with a rating
- 39
- Share rating Buy or Strong Buy
- 74%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +2.4% | -3.0% | -8.8% | -5.3% | — |
| Apr 30, 2026 | +2.5% | -0.6% | -3.5% | -2.7% | -0.4% |
| Feb 5, 2026 | +2.5% | +4.7% | +8.5% | +3.5% | +4.1% |
| Oct 30, 2025 | +2.5% | -17.4% | -13.2% | -6.9% | -9.7% |
| Jul 31, 2025 | +0.6% | -10.2% | -9.4% | +0.7% | +2.4% |
| May 2, 2025 | +6.1% | -0.1% | -0.6% | -5.5% | -12.8% |
| Jan 30, 2025 | -15.3% | -6.7% | -3.3% | -0.1% | +10.6% |
| Oct 31, 2024 | +3.9% | +0.6% | +0.7% | +7.5% | -3.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $7.78 | $7.60 | +2.4% | $71.67B |
| Apr 30, 2026 | $7.79 | $7.60 | +2.5% | $68.49B |
| Feb 5, 2026 | $8.08 | $7.88 | +2.5% | $72.47B |
| Oct 30, 2025 | $7.83 | $7.64 | +2.5% | $69.75B |
| Jul 31, 2025 | $7.20 | $7.16 | +0.6% | $67.23B |
| May 2, 2025 | $6.74 | $6.35 | +6.1% | $65.50B |
| Jan 30, 2025 | $6.64 | $7.84 | -15.3% | $65.72B |
| Oct 31, 2024 | $7.51 | $7.23 | +3.9% | $62.77B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 11.2× | 14.6× | 14th | Top 4% |
| P/E (forward) | 8.9× | — | — | — |
| EV / EBITDA | 8.2× | — | — | Top 6% |
| EV / Sales | 0.34× | — | — | Top 2% |
| Free-cash-flow yield | 12.75% | — | — | Top 5% |
| Earnings yield | 8.93% | — | — | Top 4% |
P/E over the past five years
Range 9.0× – 29.7× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -7.2%
- Earnings per share growth (TTM)
- +31.9%
- Change in P/E multiple
- -18.4%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -1.6%
- 200-day average slope (20 days)
- +0.2%
- Distance from 50-day average
- -3.0%
- Distance from 200-day average
- -3.4%
- RSI (14)
- 44.1
- Relative volume
- 1.16×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 28.1%
- Volatility vs own 5-year history
- 63th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.23
- Correlation with S&P 500
- 0.12
- Current drawdown from 1-year high
- -13.0%
- Maximum drawdown, 3 years
- -33.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 16, 2024 | Oct 31, 2025 | -33.4% | 283 days | Not yet recovered |
| Dec 12, 2022 | May 30, 2023 | -28.5% | 115 days | 181 days (Feb 16, 2024) |
| May 10, 2021 | Nov 30, 2021 | -28.1% | 142 days | 97 days (Apr 20, 2022) |
| Apr 1, 2024 | Jul 5, 2024 | -12.3% | 66 days | 41 days (Sep 3, 2024) |
| Nov 11, 2020 | Dec 22, 2020 | -11.8% | 28 days | 13 days (Jan 12, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $71.48B
- P/E (TTM)
- 11.2
- EPS, diluted (TTM)
- $24.16
- Revenue (TTM)
- $282.38B
- Dividend yield
- 2.29%
- 52-week range
- $239.51 – $315.47
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $174.07B | $180.52B | $195.26B | $247.12B | $274.95B |
| Gross profit | $22.95B | $23.50B | $25.18B | $25.96B | $25.99B |
| Operating income | $7.94B | $8.45B | $8.54B | $9.42B | $9.13B |
| Net income | $5.37B | $6.70B | $5.16B | $3.43B | $5.96B |
| EPS (diluted) | $15.75 | $21.41 | $17.39 | $12.12 | $22.17 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $63.69B | $65.65B | $65.50B | $67.23B | $69.75B | $72.47B | $68.49B | $71.67B |
| Net income | $739.0M | $1.42B | $1.32B | $1.53B | $1.87B | $1.23B | $1.65B | $1.66B |
| EPS (diluted) | $2.63 | $5.13 | $4.85 | $5.71 | $6.97 | $4.64 | $6.26 | $6.29 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $7.19B | $8.66B | $11.81B | $10.36B | $9.60B |
| Capital expenditure | -$1.15B | -$1.29B | -$1.57B | -$1.41B | -$1.21B |
| Free cash flow | $6.04B | $7.36B | $10.24B | $8.96B | $8.39B |
| Dividends paid | -$1.34B | -$1.38B | -$1.45B | -$1.57B | -$1.61B |
| Net share buybacks | -$7.42B | -$7.22B | -$2.10B | -$6.73B | -$3.42B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $6.30B
- Total assets
- $157.08B
- Total liabilities
- $114.17B
- Total debt
- $31.88B
- Net debt
- $25.58B
- Shareholders’ equity
- $42.62B
As of Jun 30, 2026 (filed Jul 30, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 8, 2026 | $1.56 | Sep 23, 2026 |
| Jun 4, 2026 | $1.56 | Jun 18, 2026 |
| Mar 5, 2026 | $1.56 | Mar 19, 2026 |
| Dec 4, 2025 | $1.51 | Dec 18, 2025 |
| Sep 4, 2025 | $1.51 | Sep 18, 2025 |
| Jun 3, 2025 | $1.51 | Jun 18, 2025 |
| Mar 5, 2025 | $1.51 | Mar 20, 2025 |
| Dec 4, 2024 | $1.40 | Dec 19, 2024 |
Short interest
- Shares sold short
- 6,562,998
- Days to cover
- 4.60
- Change vs previous report
- +4.6%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 5, 2007
- 3-for-1
- May 18, 1998
- 3-for-1